A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetes

15/07/2024
15/07/2024
EU PAS number:
EUPAS1000000260
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information
Publications